Impact of systemic corticosteroids on survival outcomes in immune checkpoint inhibitor-induced gastroenterocolitis

被引:6
|
作者
Thompson, Leah L. [1 ]
Katznelson, Ethan [1 ]
Leet, Donna E. [1 ]
Durbin, Sienna M. [1 ]
Yoon, Jaewon [1 ]
Reynolds, Kerry L. [1 ]
Dougan, Michael L. [2 ]
Chen, Steven T. [1 ,3 ]
机构
[1] Harvard Med Sch, Dept Med, Div Hematol & Oncol, Massachusetts Gen Hosp,Canc Ctr, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Med, Div Gastroenterol, Massachusetts Gen Hosp,Canc Ctr, Boston, MA 02114 USA
[3] Harvard Med Sch, Dept Dermatol, Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
MANAGEMENT;
D O I
10.1016/j.ejca.2020.09.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [21] Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury
    Abu-Sbeih, Hamzah
    Tang, Tenglong
    Lu, Yang
    Thirumurthi, Selvi
    Altan, Mehmet
    Jazaeri, Amir A.
    Dadu, Ramona
    Coronel, Emmanuel
    Wang, Yinghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [22] At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity
    Young, Arabella
    Bluestone, Jeffrey A.
    CANCER DISCOVERY, 2021, 11 (03) : 537 - 539
  • [23] Immune checkpoint inhibitor-induced granulomatosis with polyangiitis
    Hung, Whitney
    Cusnir, Ina
    Habib, Syed
    Smylie, Michael
    Solez, Kim
    Yacyshyn, Elaine
    RHEUMATOLOGY, 2021, 60 (06) : E190 - E191
  • [24] A Case of Immune Checkpoint Inhibitor-Induced Duodenitis
    Au, Sandra
    Chen, Wei
    Vance, Iris
    Wegermann, Kara
    ACG CASE REPORTS JOURNAL, 2024, 11 (10)
  • [25] Insights into immune checkpoint inhibitor-induced thyroiditis
    Melissa G. Lechner
    Mabel Ryder
    Nature Reviews Endocrinology, 2021, 17 : 643 - 644
  • [26] IMMUNE CHECKPOINT INHIBITOR-INDUCED NONINFLAMMATORY CARDIOMYOPATHY
    Parikh, Shrujal
    Nair, Ambica
    Cheriyath, Pramil
    Desai, Dhaval
    Okere, Arthur
    CHEST, 2024, 166 (04) : 846A - 847A
  • [27] Immune Checkpoint Inhibitor-induced Bilateral Vestibulopathy
    Koch, Elias A. T.
    Nickel, Florian T.
    Heinzerling, Lucie
    Schulz, Yvonne K.
    Berking, Carola
    Erdmann, Michael
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (03) : 114 - 117
  • [28] Identification of Immune Checkpoint Inhibitor-Induced Diabetes
    Ruiz-Esteves, Karina N.
    Shank, Kaitlyn R.
    Deutsch, Aaron J.
    Gunturi, Alekhya
    Chamorro-Pareja, Natalia
    Colling, Caitlin A.
    Zubiri, Leyre
    Perlman, Katherine
    Ouyang, Tianqi
    Villani, Alexandra-Chloe
    Florez, Jose C.
    Gusev, Alexander
    Reynolds, Kerry L.
    Miller, Karen K.
    Udler, Miriam S.
    Sise, Meghan E.
    Rengarajan, Michelle
    JAMA ONCOLOGY, 2024, 10 (10) : 1409 - 1416
  • [29] Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
    Jimenez-Alejandre, Rosa
    Ruiz-Fernandez, Ignacio
    Martin, Pilar
    CANCERS, 2022, 14 (18)
  • [30] Immune checkpoint inhibitor-induced musculoskeletal manifestations
    Angelopoulou, Foteini
    Bogdanos, Dimitrios
    Dimitroulas, Theodoros
    Sakkas, Lazaros
    Daoussis, Dimitrios
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (01) : 33 - 42